Dr. Bernstein is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
410 Lakeville Road
Suite 311
New Hyde Park, NY 11042Phone+1 516-838-6415Fax+1 516-465-5226
Education & Training
- Tower Health/St. Christopher's Hospital for ChildrenResidency, Pediatrics, 1982 - 1985
- Rowan University School of Osteopathic MedicineClass of 1982
Certifications & Licensure
- NJ State License 1983 - Present
- MA State License 1995 - 2026
- NY State License 2010 - 2026
- NH State License 2005 - 2019
- PA State License 1983 - 1996
- American Board of Pediatrics Pediatrics
Awards, Honors, & Recognition
- Physician Practice Connections Recognition Program National Committee for Quality Assurance, 2010-2013
- Patient-Centered Medical Home Recognition Program National Committee for Quality Assurance, 2010-2013
Publications & Presentations
PubMed
- 10 citationsComparison of the safety and immunogenicity of a refrigerator-stable versus a frozen formulation of ProQuad (measles, mumps, rubella, and varicella virus vaccine live).Henry H. Bernstein, Karen Eves, Kristy Campbell, Steven Black, Jerry D. Twiggs
Pediatrics. 2007-06-01 - 18 citationsRecommended immunization schedules for children and adolescents - United States, 2008Joseph A. Bocchini, Henry H. Bernstein, John S. Bradley, Michael T. Brady, Carrie L. Byington
Pediatrics. 2008-01-01 - 116 citationsImmune responses in infants whose mothers received Tdap vaccine during pregnancy.Abbey J Hardy-Fairbanks, Stephanie J. Pan, Michael D. Decker, David R. Johnson, David P. Greenberg
The Pediatric Infectious Disease Journal. 2013-11-01
Press Mentions
- FDA Advisors Vote in Favor of Pfizer’s RSV Vaccine to Protect InfantsMay 18th, 2023
- FDA Panel Backs Second RSV Vaccine for Older AmericansMarch 2nd, 2023
- FDA Panel Backs Second RSV Vaccine for Older AmericansMarch 2nd, 2023
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: